AbCellera Stock Analysis - Why ABCL Stock is Falling
Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/g7m-Gs9_UB8.
AbCellera stock hasn't been treating investors well at any time frame as ABCL stock hits 52-week lows. While AbCellera has plenty of cash and runway, we're more concerned with how quickly they're progressing molecules into the clinic. Now that Eli Lilly's revenues have dried up, we can now have a better picture of the company's…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.